Cannabinoid Type 2 (CB2) Receptors Activation Protects against Oxidative Stress and Neuroinflammation Associated Dopaminergic Neurodegeneration in Rotenone Model of Parkinson's Disease
出版年份 2016 全文链接
标题
Cannabinoid Type 2 (CB2) Receptors Activation Protects against Oxidative Stress and Neuroinflammation Associated Dopaminergic Neurodegeneration in Rotenone Model of Parkinson's Disease
作者
关键词
-
出版物
Frontiers in Neuroscience
Volume 10, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2016-08-02
DOI
10.3389/fnins.2016.00321
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Polypharmacological Properties and Therapeutic Potential of β-Caryophyllene: A Dietary Phytocannabinoid of Pharmaceutical Promise
- (2016) Charu Sharma et al. CURRENT PHARMACEUTICAL DESIGN
- Potential of the cannabinoid CB2 receptor as a pharmacological target against inflammation in Parkinson's disease
- (2016) Yolanda Gómez-Gálvez et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Expression of Tgfβ1 and Inflammatory Markers in the 6-hydroxydopamine Mouse Model of Parkinson’s Disease
- (2016) Stefan Jean-Pierre Haas et al. Frontiers in Molecular Neuroscience
- Differential upregulation of the cannabinoid CB2 receptor in neurotoxic and inflammation-driven rat models of Parkinson's disease
- (2015) Ruth M. Concannon et al. EXPERIMENTAL NEUROLOGY
- Nrf2—a therapeutic target for the treatment of neurodegenerative diseases
- (2015) Delinda A. Johnson et al. FREE RADICAL BIOLOGY AND MEDICINE
- Identification of CB2 receptors in human nigral neurons that degenerate in Parkinson’s disease
- (2015) María Concepción García et al. NEUROSCIENCE LETTERS
- Glycyrrhizic acid Attenuates Neuroinflammation and Oxidative Stress in Rotenone Model of Parkinson’s Disease
- (2015) Shreesh Ojha et al. NEUROTOXICITY RESEARCH
- Neuroinflammation in Parkinson’s disease and its potential as therapeutic target
- (2015) Qinqin Wang et al. Translational Neurodegeneration
- Inflammatory response in Parkinson’s disease (Review)
- (2014) JUNQIANG YAN et al. Molecular Medicine Reports
- The cannabinoid receptor 2 agonist, β-caryophyllene, reduced voluntary alcohol intake and attenuated ethanol-induced place preference and sensitivity in mice
- (2014) Shamma Al Mansouri et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- β-Caryophyllene, a CB2 receptor agonist produces multiple behavioral changes relevant to anxiety and depression in mice
- (2014) Amine Bahi et al. PHYSIOLOGY & BEHAVIOR
- Cannabinoid CB2receptors modulate midbrain dopamine neuronal activity and dopamine-related behavior in mice
- (2014) Hai-Ying Zhang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Activation of Cannabinoid CB2 Receptor–Mediated AMPK/CREB Pathway Reduces Cerebral Ischemic Injury
- (2013) In-Young Choi et al. AMERICAN JOURNAL OF PATHOLOGY
- Pomegranate juice exacerbates oxidative stress and nigrostriatal degeneration in Parkinson's disease
- (2013) Victor Tapias et al. NEUROBIOLOGY OF AGING
- Selective binding of nuclear alpha-synuclein to the PGC1alpha promoter under conditions of oxidative stress may contribute to losses in mitochondrial function: Implications for Parkinson’s disease
- (2012) Almas Siddiqui et al. FREE RADICAL BIOLOGY AND MEDICINE
- Proteolytic activation of proapoptotic kinase protein kinase Cδ by tumor necrosis factor α death receptor signaling in dopaminergic neurons during neuroinflammation
- (2012) Richard Gordon et al. Journal of Neuroinflammation
- Anti-inflammatory properties rather than anti-oxidant capability is the major mechanism of neuroprotection by sodium salicylate in a chronic rotenone model of Parkinson’s disease
- (2012) P. Thakur et al. NEUROSCIENCE
- The anxiolytic-like effect of an essential oil derived from Spiranthera odoratissima A. St. Hil. leaves and its major component, β-caryophyllene, in male mice
- (2012) Pablinny Moreira Galdino et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- β-Caryophyllene Inhibits Dextran Sulfate Sodium-Induced Colitis in Mice through CB2 Receptor Activation and PPARγ Pathway
- (2011) Allisson Freire Bento et al. AMERICAN JOURNAL OF PATHOLOGY
- Symptom-relieving and neuroprotective effects of the phytocannabinoid Δ9-THCV in animal models of Parkinson's disease
- (2011) C García et al. BRITISH JOURNAL OF PHARMACOLOGY
- AM630 behaves as a protean ligand at the human cannabinoid CB2 receptor
- (2011) Daniele Bolognini et al. BRITISH JOURNAL OF PHARMACOLOGY
- Evidence that -Secretase-Mediated Notch Signaling Induces Neuronal Cell Death via the Nuclear Factor- B-Bcl-2-Interacting Mediator of Cell Death Pathway in Ischemic Stroke
- (2011) T. V. Arumugam et al. MOLECULAR PHARMACOLOGY
- Effects of endocannabinoid system modulation on cognitive and emotional behavior
- (2011) Claudio Zanettini Frontiers in Behavioral Neuroscience
- WIN55212-2 ameliorates atherosclerosis associated with suppression of pro-inflammatory responses in ApoE-knockout mice
- (2010) Yan Zhao et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Antispasmodic effects of essential oil of Pterodon polygalaeflorus and its main constituent β-caryophyllene on rat isolated ileum
- (2010) Valeria Leonhardt et al. FUNDAMENTAL & CLINICAL PHARMACOLOGY
- International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid Receptors and Their Ligands: Beyond CB1 and CB2
- (2010) R. G. Pertwee et al. PHARMACOLOGICAL REVIEWS
- Neuroprotective effects of hydrogen sulfide on Parkinson’s disease rat models
- (2009) Li-Fang Hu et al. AGING CELL
- Microglial CB2 cannabinoid receptors are neuroprotective in Huntington's disease excitotoxicity
- (2009) Javier Palazuelos et al. BRAIN
- WIN55,212-2, a cannabinoid receptor agonist, protects against nigrostriatal cell loss in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson’s disease
- (2009) David A. Price et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- Cannabinoid CB2receptor agonists protect the striatum against malonate toxicity: Relevance for Huntington's disease
- (2009) Onintza Sagredo et al. GLIA
- Melatonin and its brain metabolite N1-acetyl-5-methoxykynuramine prevent mitochondrial nitric oxide synthase induction in parkinsonian mice
- (2009) Víctor Tapias et al. JOURNAL OF NEUROSCIENCE RESEARCH
- A highly reproducible rotenone model of Parkinson's disease
- (2009) Jason R. Cannon et al. NEUROBIOLOGY OF DISEASE
- Ethyl pyruvate protects against hypoxic-ischemic brain injury via anti-cell death and anti-inflammatory mechanisms
- (2009) Hongxia Shen et al. NEUROBIOLOGY OF DISEASE
- The Therapeutic Potential of the Endocannabinoid System for the Development of a Novel Class of Antidepressants
- (2009) Matthew N. Hill et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- The CB2Cannabinoid Receptor Controls Myeloid Progenitor Trafficking
- (2008) Javier Palazuelos et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The selective nonpeptide CXCR2 antagonist SB225002 ameliorates acute experimental colitis in mice
- (2008) Allisson Freire Bento et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Beta-caryophyllene is a dietary cannabinoid
- (2008) Jürg Gertsch et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cannabinoid receptor stimulation is anti-inflammatory and improves memory in old rats
- (2007) Yannick Marchalant et al. NEUROBIOLOGY OF AGING
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started